Prestige Consumer Healthcare Inc. to Post Q1 2025 Earnings of $0.86 Per Share, DA Davidson Forecasts (NYSE:PBH)

Prestige Consumer Healthcare Inc. (NYSE:PBHFree Report) – Equities researchers at DA Davidson issued their Q1 2025 EPS estimates for Prestige Consumer Healthcare in a research report issued to clients and investors on Thursday, May 16th. DA Davidson analyst L. Weiser anticipates that the company will post earnings per share of $0.86 for the quarter. DA Davidson currently has a “Neutral” rating and a $65.00 target price on the stock. The consensus estimate for Prestige Consumer Healthcare’s current full-year earnings is $4.41 per share. DA Davidson also issued estimates for Prestige Consumer Healthcare’s FY2025 earnings at $4.41 EPS and FY2026 earnings at $4.80 EPS.

Prestige Consumer Healthcare (NYSE:PBHGet Free Report) last released its quarterly earnings data on Tuesday, May 14th. The company reported $1.02 EPS for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.12). Prestige Consumer Healthcare had a net margin of 18.60% and a return on equity of 13.48%. The firm had revenue of $277.00 million during the quarter, compared to the consensus estimate of $287.42 million. During the same quarter last year, the business posted $1.07 earnings per share. Prestige Consumer Healthcare’s revenue was down 3.1% compared to the same quarter last year.

Other equities research analysts have also issued reports about the stock. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, May 13th. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.00.

Get Our Latest Analysis on PBH

Prestige Consumer Healthcare Trading Down 0.5 %

Shares of Prestige Consumer Healthcare stock opened at $64.65 on Friday. Prestige Consumer Healthcare has a 1 year low of $55.96 and a 1 year high of $75.31. The firm has a market cap of $3.23 billion, a PE ratio of 15.50, a PEG ratio of 1.84 and a beta of 0.53. The company has a debt-to-equity ratio of 0.68, a current ratio of 3.20 and a quick ratio of 1.92. The company has a 50 day simple moving average of $70.69 and a two-hundred day simple moving average of $65.23.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Tidal Investments LLC raised its stake in shares of Prestige Consumer Healthcare by 4.7% during the first quarter. Tidal Investments LLC now owns 5,748 shares of the company’s stock worth $417,000 after acquiring an additional 256 shares in the last quarter. Bayesian Capital Management LP purchased a new position in shares of Prestige Consumer Healthcare during the first quarter worth approximately $213,000. Public Employees Retirement System of Ohio increased its stake in shares of Prestige Consumer Healthcare by 20.5% in the first quarter. Public Employees Retirement System of Ohio now owns 80,950 shares of the company’s stock worth $5,874,000 after buying an additional 13,760 shares during the period. BOKF NA purchased a new position in shares of Prestige Consumer Healthcare in the first quarter worth $246,000. Finally, Quadrature Capital Ltd increased its stake in shares of Prestige Consumer Healthcare by 75.8% in the first quarter. Quadrature Capital Ltd now owns 9,193 shares of the company’s stock worth $668,000 after buying an additional 3,965 shares during the period. 99.95% of the stock is owned by hedge funds and other institutional investors.

About Prestige Consumer Healthcare

(Get Free Report)

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

See Also

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.